Codiak BioSciences Performance
Codiak BioSciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Codiak BioSciences on April 27, 2025 and sell it today you would earn a total of 100.00 from holding Codiak BioSciences or generate -100.0% return on investment over 90 days. Codiak BioSciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Codiak, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Codiak BioSciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Codiak BioSciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Codiak BioSciences, and traders can use it to determine the average amount a Codiak BioSciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CDAKQ |
Based on monthly moving average Codiak BioSciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Codiak BioSciences by adding Codiak BioSciences to a well-diversified portfolio.
Things to note about Codiak BioSciences performance evaluation
Checking the ongoing alerts about Codiak BioSciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Codiak BioSciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Codiak BioSciences is not yet fully synchronised with the market data | |
| Codiak BioSciences has some characteristics of a very speculative penny stock |
- Analyzing Codiak BioSciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Codiak BioSciences' stock is overvalued or undervalued compared to its peers.
- Examining Codiak BioSciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Codiak BioSciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Codiak BioSciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Codiak BioSciences' pink sheet. These opinions can provide insight into Codiak BioSciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Codiak Pink Sheet
If you are still planning to invest in Codiak BioSciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Codiak BioSciences' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |